24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Chiasma
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
14:26
The content collapse: How AI broke the internet’s oldest business model
14:02
Pango reboots Gett deal with Leumi Partners and decentralized investor group
13:00
Cyera doubles valuation to $6 billion with $540M Series E
10:12
Who inherits your cloud? Preparing for digital legacy in the age of data
More stories
Buzz
Most popular
Daily
Weekly
1
Andreessen Horowitz targets elite IDF alumni for startup accelerator
2
Tastewise raises $50M to power the AI brain behind Kraft, Mars, and Campbell’s
3
Guardz raises $56M to bring enterprise-level cybersecurity to small businesses
4
From the Great Synagogue to the King David Hotel: Who really owns Jerusalem’s land?
5
Once a $400M prospect, Autotalks sold to Qualcomm for less than $100M
More news
Chiasma
1 stories about Chiasma
Nasdaq-Listed Biopharma Company Chiasma Raises $34.5 Million in Public Offering
09.04.19
|
CTech
Chiasma develops octreotide capsules for the treatment of acromegaly, a rare, chronic disease typically caused by a benign tumor of the pituitary gland